Correction to: J Cardiothorac Surg
https://doi.org/10.1186/s13019-019-0831-0
The original article [1] contains slight errors whereby several terms in the first column of Tables 1, 2, and 3 have an erroneous ‘p’ preceding them. The correct presentation of these tables can be viewed ahead.
Table 1.
Characteristics | Number of Patients (n) | Percentage |
---|---|---|
Tumor-localization | ||
central | 53 | 26.2% |
peripheral | 149 | 73.8% |
Histology | ||
adenocarcinoma | 117 | 57.4% |
SCCa | 75 | 36.8% |
others | 12 | 5.9% |
Grading | ||
In situ | 2 | 1% |
G1 | 25 | 12.4% |
G2 | 95 | 47.0% |
G3 | 68 | 33.3% |
G4 | 12 | 5.9% |
pT-category | ||
pTis | 2 | 1% |
pT1 | 90 | 45.1% |
pT1a | 10 | 4.9% |
pT1b | 37 | 18.1% |
pT1c | 43 | 21.1% |
pT2 | 44 | 26.5 |
pT2a | 39 | 19.1% |
pT2b | 15 | 7.4% |
pT3 | 35 | 17.2% |
pT4 | 23 | 11.3 |
pN-category | ||
pN0 | 126 | 61.8% |
pN1 | 33 | 16.2% |
pN2 | 45 | 22% |
pM-category | ||
pM0 | 193 | 94.5% |
pM1a | 5 | 2.5% |
pM1b | 5 | 2.5% |
pM1c | 1 | 0.5% |
L-Status | ||
L0 | 57 | 28.1% |
L1 | 146 | 71.9% |
V-Status | ||
V0 | 165 | 81.3% |
V1 | 38 | 18.7% |
aSCC Squamous cell carcinoma
Table 2.
Variables | pN1- (%) | pN1+ (%) | P-Value | pN2- (%) | pN2+ (%) | P-Value |
---|---|---|---|---|---|---|
Sex | 0.148 | 0.627 | ||||
male | 90 (63.4) | 52 (36.6) | 112 (78.9) | 30 (21.1) | ||
female | 46 (74.2) | 16 (25.8) | 47 (75.8) | 15 (24.2) | ||
Age | 0.298 | 0.237 | ||||
≤ 68 years | 68 (63) | 40 (37) | 88 (81.5) | 20 (81.5) | ||
> 68 years | 68 (70.8) | 28 (29.2) | 71 (74.0) | 25 (21.2) | ||
Tumor site | 0.067 | 0.783 | ||||
right | 90 (71.4) | 36 (28.6) | 99 (78.6) | 27 (21.4) | ||
left | 46 (59) | 32 (41) | 60 (76.9) | 18 (23.1) | ||
Tumor localization | < 0.001 | 0.02 | ||||
central | 25 (47.2) | 28 (52.8) | 36 (66.7) | 18 (33.3) | ||
peripheral | 111 (74.5) | 38 (25.5) | 122 (81.9) | 27 (18.1) | ||
Tumor size | 0.011 | 0.042 | ||||
≤ 3 cm | 77 (75.5) | 25 (24.5) | 86 (84.3) | 16 (15.7) | ||
> 3 cm | 59 (57.8) | 43 (42.8) | 73 (71.6) | 29 (28.4) | ||
Lobe distribution | 0.918 | 0.385 | ||||
ULa | 85 (66.4) | 43 (33.6) | 97 (75.8) | 31 (24.2) | ||
Non-UL | 51 (67.1) | 25 (32.9) | 62 (81.6) | 14 (18.4) | ||
pT-category | 0.015 | 0.081 | ||||
pT1 | 70 (77.8) | 20 (22.2) | 77 (85.6) | 13 (14.4) | ||
pT2 | 33 (61.1) | 21 (38.9) | 40 (74.1) | 14 (25.9) | ||
pT3 | 18 (51.4) | 17 (48.6) | 23 (65.7) | 12 (34.3) | ||
pT4 | 13 (56.5) | 10 (43.5) | 17 (73.9) | 6 (26.1) | ||
R-classification | 0.017 | 0.088 | ||||
R0 | 130 (68.8) | 59 (31.2) | 150 (79.4) | 39 (20.6) | ||
R1–2 | 5 (35.7) | 9 (64.3) | 8 (57.1) | 6 (42.9) | ||
L-status | < 0.001 | < 0.001 | ||||
L0 | 55 (96.5) | 2 (3.5) | 56 (98.2) | 1 (1.8) | ||
L1 | 80 (54.8) | 66 (45.2) | 102 (69.9) | 44 (30.1) | ||
V-status | 0.006 | 0.004 | ||||
V0 | 117 (70.9) | 48 (29.1) | 135 (81.1) | 30 (18.2) | ||
V | 18 (47.4) | 20 (52.6) | 23 (60.5) | 15 (39.5) | ||
Pn-Status | 0.088 | 0.34 | ||||
Pn0 | 131 (67.9) | 62 (32.1) | 149 (77.2) | 44 (22.8) | ||
Pn1 | 4 (40.0) | 6 (60.0) | 9 (90.0) | 1 (10.0) | ||
Histological tumor type | 0.214 | 0.646 | ||||
Adeno-Ca.b | 84 (71.8) | 33 (28.2) | 94 (80.3) | 23 (19.7) | ||
56 (74.4) | 19 (25.6) | |||||
SCCc | 45 (60.0) | 30 (40.0) | 9 (75.0) | 3 (25.0) | ||
others | 7 (58.3) | 5 (41.7) | ||||
Grading | 0.016 | 0.001 | ||||
G1 | 25 (89.3) | 3 (10.7) | 27 (96.4) | 1 (3.6) | ||
G2 | 64 (67.4) | 31 (32.6) | 79 (83.2) | 16 (16.8) | ||
G3 | 39 (57.4) | 29 (42.6) | 43 (63.2) | 25 (36.8) | ||
G4 | 7 (58.3) | 5 (41.7) | 9 (75.0) | 3 (25.0) |
aUL Upper lobe, bAdeno-Ca. Adenocarcinoma, cSCC Squamous cell carcinoma
Table 3.
Variables | pN0 (%) | pN+ (%) | P-Value |
---|---|---|---|
Sex | 0.397 | ||
male | 85 (59.9) | 57 (40.1) | |
female | 41 (66.1) | 21 (33.9) | |
Age | 0.314 | ||
≤ 68 years | 63 (58.3) | 45 (41.7) | |
> 68 years | 63 (65.6) | 33 (34.4) | |
Tumor site | 0.067 | ||
Right | 84 (66.7) | 42 (33.3) | |
Left | 42 (53.8) | 36 (46.2) | |
Tumor localization | < 0.001 | ||
central | 22 (41.5) | 31 (58.5) | |
peripheral | 104 (69.8) | 45 (30.2) | |
Tumor size | < 0.001 | ||
≤ 3 cm | 76 (74.5) | 26 (25.5) | |
> 3 cm | 50 (49) | 52 (51) | |
Lobe distribution | 0.834 | ||
UL a | 78 (60.9) | 50 (39.1) | |
Non-UL | 40 (62.5) | 24 (37.5) | |
Number of dissected LN b | 0.005 | ||
pT-category | 0.001 | ||
pT1 | 69 (76.7) | 21 (23.3) | |
pT2 | 27 (50.9) | 26 (49.1) | |
pT3 | 17 (47.2) | 19 (52.8) | |
pT4 | 11 (47.8) | 12 (52.2) | |
R-classification | 0.048 | ||
R0 | 120 (96.0) | 5 (4.0) | |
R1–2 | 69 (88.5) | 9 (11.5) | |
L-status | < 0.001 | ||
L0 | 54 (94.7) | 3 (5.3) | |
L1 | 71 (48.6) | 75 (51.4) | |
V-status | 0.001 | ||
V0 | 111 (67.3) | 54 (32.7) | |
V1 | 14 (36.8) | 24 (63.2) | |
Pn-status | 0.188 | ||
Pn0 | 121 (96.8) | 4 (3.2) | |
Pn1 | 72 (92.3) | 6 (7.7) | |
Histological tumor type | 0.141 | ||
Adeno-Ca.b | 79 (67.5) | 38 (32.5) | |
SCCc | 41 (54.7) | 34 (45.3) | |
others | 6 (50.0) | 6 (50.0) | |
Grading | 0.005 | ||
G1 | 22 (88.0) | 3 (12.0) | |
G2 | 60 (63.2) | 35 (36.8) | |
G3 | 34 (50.0) | 34 (50.0) | |
G4 | 6 (50.0) | 6 (50.0) |
aUL Upper lobe, bAdeno-Ca. Adenocarcinoma, cSCC Squamous cell carcinoma
Reference
- 1.Moulla Y, et al. Predictive risk factors for lymph node metastasis in patients with resected non-small cell lung cancer: a case control study. J Cardiothorac Surg. 2019;14:11. doi: 10.1186/s13019-019-0831-0. [DOI] [PMC free article] [PubMed] [Google Scholar]